Dr. Reddy's Laboratories Limited: Fasting trials

The registry lists 12 Fasting studies with Dr. Reddy's Laboratories Limited as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fasting ConditionsCompletedNCT01621750Phase 1
• Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting ConditionsCompletedNCT01506713Phase 1
• Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fasting ConditionsCompletedNCT01506076Phase 1
• Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fasting ConditionsCompletedNCT01506011Phase 1
• Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting ConditionCompletedNCT01503437Phase 1
• Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting ConditionsCompletedNCT01503398Phase 1
• Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Fasting ConditionsCompletedNCT01372345Phase 1
• Galantamine Bioequivalence Study of Dr. Reddy's Under Fasting ConditionCompletedNCT01372280Phase 1
• Bioavailability Study of Dr. Reddy's Desloratadine Tablets, 5 mg Under Fasting Conditions.CompletedNCT01314339Phase 1
• Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fasting ConditionsCompletedNCT01286688Phase 1
• Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fasting ConditionCompletedNCT01283919Phase 1
• Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Laboratories Limited Under Fasting ConditionsCompletedNCT01283841Phase 1